Led by Zumin Shi, MD, PhD, of the University of Adelaide, researchers conducted computer assisted telephone interviewing among 16,907 participants aged 16 years and older in South Australia between March 2008 and June 2010 inquiring about soft drink consumption. Soft drinks comprised Coke, lemonade, flavored mineral water, Powerade, and Gatorade etc.
Results showed that one in ten adults drink more than half a liter of soft drink daily in South Australia. The amount of soft drink consumption is associated with an increased chance of asthma and/or COPD. There exists a dose-response relationship, which means the more soft drink one consumes, the higher the chance of having these diseases.
Overall, 13.3% of participants with asthma and 15.6% of those with COPD reported consuming more than half a liter of soft drink per day.
The odds ratio for asthma and COPD was 1.26 and 1.79, comparing those who consumed more than half a liter of soft drink per day with those who did not consume soft drinks.
Furthermore, smoking makes this relationship even worse, especially for COPD. Compared with those who did not smoke and consume soft drinks, those that consumed more than half a liter of soft drink per day and were current smokers had a 6.6-fold greater risk of COPD.
“Our study emphasizes the importance of healthy eating and drinking in the prevention of chronic diseases like asthma and COPD,” Zumin concludes.
This study is published in the journal Respirology. Media wishing to receive a PDF of this article may contact firstname.lastname@example.org.
Full citation: SHI, Z., DAL GRANDE, E., TAYLOR, A. W., GILL, T. K., ADAMS, R. and WITTERT, G. A. (2012), Association between soft drink consumption and asthma and chronic obstructive pulmonary disease among adults in Australia. Respirology, 17: 363–369. doi: 10.1111/j.1440-1843.2011.02115.x
About the Author: Dr. Shi is affiliated with the University of Adelaide.
To arrange an interview with Dr. Shi, please contact Zumin.email@example.com.
About the Journal:
Respirology is a journal of international standing, publishing peer-reviewed articles of scientific excellence in clinical and experimental respiratory biology and disease and its related fields of research including thoracic surgery, internal medicine, immunology, intensive and critical care, epidemiology, cell and molecular biology, pathology, pharmacology, physiology and pediatric respiratory medicine. For more information about the journal, please visit http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1440-1843.
Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world’s leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit www.wileyblackwell.com or our new online platform, Wiley Online Library (wileyonlinelibrary.com), one of the world’s most extensive multidisciplinary collections of online resources, covering life, health, social and physical sciences, and humanities.
For advertising and promotion on HealthNewsDigest.com please contact Mike McCurdy: tvmike13@HealthNewsDigest.com or 877-634-9180
HealthNewsDigest.com is syndicated worldwide and has over 7,000 journalists as subscribers.